According to data from National Securities Depository Limited (NSDL) and National Stock Exchange (NSE), FIIs sold shares worth more than Rs 2,000 crore between August 18 and 22. During the same period, Sensex and Nifty rose by about 1%, while BSE MidCap and SmallCap indices jumped by more than 2%. This rise was made possible by purchases worth about Rs 10,000 crore by domestic investors.
The promoter of the company has bought 40,000 shares from the open market on 21 August. This purchase by the promoter shows confidence in the company's business. This promoter support for Welspun Enterprises, which is active in infrastructure and development projects, is a positive message for investors.
L&T report its #Q1 earnings;
▶️Net Profit At ₹3,617 Cr Vs CNBC-TV18 Poll Of ₹3,387 Cr
▶️Revenue At ₹63,678 Cr Vs CNBC-TV18 Poll Of ₹62,829 Cr
▶️EBITDA At ₹6,316 Cr Vs CNBC-TV18 Poll Of ₹6,362 Cr
▶️Margin At 9.9% Vs CNBC-TV18 Poll Of 10.1%
▶️Net Profit At ₹3,617 Cr Vs CNBC-TV18 Poll Of ₹3,387 Cr
▶️Revenue At ₹63,678 Cr Vs CNBC-TV18 Poll Of ₹62,829 Cr
▶️EBITDA At ₹6,316 Cr Vs CNBC-TV18 Poll Of ₹6,362 Cr
▶️Margin At 9.9% Vs CNBC-TV18 Poll Of 10.1%
#EmcurePharma reports its #Q1 earnings:
👉Net Profit Up 44% At ₹207 Cr Vs ₹144 Cr (YoY)
👉Revenue Up 15.7% At ₹2,100 Cr Vs ₹1,815 Cr (YoY)
👉EBITDA Up 24% At ₹417 Cr Vs ₹336.4 Cr (YoY)
👉Margin At 20% Vs 18.5% (YoY)
👉Net Profit Up 44% At ₹207 Cr Vs ₹144 Cr (YoY)
👉Revenue Up 15.7% At ₹2,100 Cr Vs ₹1,815 Cr (YoY)
👉EBITDA Up 24% At ₹417 Cr Vs ₹336.4 Cr (YoY)
👉Margin At 20% Vs 18.5% (YoY)
Godrej Cons report #Q1Results;
👉Net Profit At ₹452.5 Cr Vs ₹480 Cr
👉Revenue At ₹3,662 Cr Vs ₹3,665 Cr
👉EBITDA At ₹694.8 Cr Vs ₹739 Cr
👉Margin At 19% Vs 20.2%
👉Net Profit At ₹452.5 Cr Vs ₹480 Cr
👉Revenue At ₹3,662 Cr Vs ₹3,665 Cr
👉EBITDA At ₹694.8 Cr Vs ₹739 Cr
👉Margin At 19% Vs 20.2%
RITES reports #Q1results
Net profit up 0.7% at ₹91 cr vs ₹90.4 cr (YoY)
Revenue up 0.8% at ₹489.7 cr vs ₹485.8 cr (YoY)
EBITDA up 7.8% at ₹114 cr vs ₹106 cr (YoY)
Margin at 23.3% vs 21.8% (YoY)
Net profit up 0.7% at ₹91 cr vs ₹90.4 cr (YoY)
Revenue up 0.8% at ₹489.7 cr vs ₹485.8 cr (YoY)
EBITDA up 7.8% at ₹114 cr vs ₹106 cr (YoY)
Margin at 23.3% vs 21.8% (YoY)
💎#BayerCrop
reports its #Q1 earnings:
👉Net Profit Up 9.6% At ₹278.7 Cr Vs ₹254 Cr (YoY)
👉Revenue Up 17.4% At ₹1,914.6 Cr Vs ₹1,631.4 Cr (YoY)
👉EBITDA Up 11% At ₹348.5 Cr Vs ₹314 Cr (YoY)
👉Margin At 18.2% Vs 19.3% (YoY)
reports its #Q1 earnings:
👉Net Profit Up 9.6% At ₹278.7 Cr Vs ₹254 Cr (YoY)
👉Revenue Up 17.4% At ₹1,914.6 Cr Vs ₹1,631.4 Cr (YoY)
👉EBITDA Up 11% At ₹348.5 Cr Vs ₹314 Cr (YoY)
👉Margin At 18.2% Vs 19.3% (YoY)